Just a moment...
Generate professional replies to Show Cause Notices, assessment orders, audit objections, and other legal communications using TaxTMI's AI Drafter.
Step 1 – Issue Identification & Review
The AI analyses your query, notice, order, or uploaded documents and identifies the key issues involved.
• Review the issues identified by the AI
• Add, edit, remove, or refine issues as required
Step 2 – Draft Generation
Once you approve the issues, the AI performs issue-wise legal research and prepares a structured draft response.
• Relevant statutory provisions
• Judicial precedents and Supreme Court, High Court and other citations
• Issue-wise legal analysis
• Practical arguments and supporting content
• Professionally structured draft ready for further review. 
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: Whether the respondent was entitled to Cenvat credit on the disputed product, in view of the prescribed dosage quantity under Notification No. 5/86 and the product's tax treatment under the Central Excise and State Excise regimes.
Analysis: The disputed product was found to be similar to the product considered in an earlier High Court decision, where a dosage unit below the prescribed minimum quantity was held to be liable to Central Excise duty and eligible for Modvat/Cenvat credit, and not liable to State Excise duty under the Medicinal and Toilet Preparations (Excise Duties) Act, 1955. Applying that ratio to the present product, the Tribunal accepted that the same legal position governed the respondent's claim.
Conclusion: The respondent was held entitled to credit, and the Revenue's appeal was rejected.
Final Conclusion: The decision affirms the availability of credit where the product falls within the same taxing treatment as an earlier binding decision on an identical issue.
Ratio Decidendi: Where a product is materially identical to one already held to be exigible to Central Excise duty and eligible for Modvat/Cenvat credit, the same classification and credit entitlement must follow.